Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix (Q38494130)
Jump to navigation
Jump to search
scientific article published on 24 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix |
scientific article published on 24 February 2011 |
Statements
1 reference
Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix (English)
1 reference
Jong Ha Hwang
1 reference
Sang-Soo Seo
1 reference
Sang-Yoon Park
1 reference
24 February 2011
1 reference
1 reference
41
1 reference
5
1 reference
624-629
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference